224 related articles for article (PubMed ID: 29429869)
1. Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?
Abbott R; Chang DD; Eyre HA; Bousman CA; Merrill DA; Lavretsky H
Am J Geriatr Psychiatry; 2018 Feb; 26(2):125-133. PubMed ID: 29429869
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
[TBL] [Abstract][Full Text] [Related]
3. Moving pharmacoepigenetics tools for depression toward clinical use.
Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
[TBL] [Abstract][Full Text] [Related]
5. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
6. An update on antidepressant pharmacotherapy in late-life depression.
Brender R; Mulsant BH; Blumberger DM
Expert Opin Pharmacother; 2021 Oct; 22(14):1909-1917. PubMed ID: 33910422
[No Abstract] [Full Text] [Related]
7. Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.
Bousman CA; Forbes M; Jayaram M; Eyre H; Reynolds CF; Berk M; Hopwood M; Ng C
BMC Psychiatry; 2017 Feb; 17(1):60. PubMed ID: 28178974
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions.
Marshe VS; Islam F; Maciukiewicz M; Bousman C; Eyre HA; Lavretsky H; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
Am J Geriatr Psychiatry; 2020 Jun; 28(6):609-629. PubMed ID: 32122803
[TBL] [Abstract][Full Text] [Related]
9. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
Hizel HC
Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
[No Abstract] [Full Text] [Related]
10. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M
BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555
[TBL] [Abstract][Full Text] [Related]
11. Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.
Bousman CA; Dunlop BW
Pharmacogenomics J; 2018 Sep; 18(5):613-622. PubMed ID: 29795409
[TBL] [Abstract][Full Text] [Related]
12. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Weitzel KW; Cavallari LH; Lesko LJ
Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
[TBL] [Abstract][Full Text] [Related]
13. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine, pharmacogenomic and companion biomarker.
Manceau H; Amrani K; Peoc'h K
Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
[TBL] [Abstract][Full Text] [Related]
15. The role of depression pharmacogenetic decision support tools in shared decision making.
Arandjelovic K; Eyre HA; Lenze E; Singh AB; Berk M; Bousman C
J Neural Transm (Vienna); 2019 Jan; 126(1):87-94. PubMed ID: 29082439
[TBL] [Abstract][Full Text] [Related]
16. Integrating pharmacogenomics into electronic health records with clinical decision support.
Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
[TBL] [Abstract][Full Text] [Related]
17. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategy for late-life depression.
Baba H
PCN Rep; 2023 Jun; 2(2):e91. PubMed ID: 38868144
[TBL] [Abstract][Full Text] [Related]
19. Disease-drug database for pharmacogenomic-based prescribing.
Hussain S; Kenigsberg BB; Danahey K; Lee YM; Galecki PM; Ratain MJ; O'Donnell PH
Clin Pharmacol Ther; 2016 Aug; 100(2):179-90. PubMed ID: 26940584
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and ALL treatment: How to optimize therapy.
Karol SE; Yang JJ
Semin Hematol; 2020 Jul; 57(3):130-136. PubMed ID: 33256902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
